InsiderTrades

Form 4 for FENC FENNEC PHARMACEUTICALS INC.

Accepted 2024-04-18 00:00:00 ET · period of report 2024-04-17 · accession 0001415889-24-011190 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-04-18 2024-04-17+ FENC Haigh Adrian COO S - Sale $6.04 0 44.4K New $0
DM 2024-04-18 2024-04-17+ FENC Haigh Adrian COO M - OptEx $2.31 -44.4K 426.9K -9% -$102.7K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Shares 2024-04-17 S A 22,222 $2.31 22,222 D — — (F1) Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.
2 Common Common Shares 2024-04-18 S D 22,222 $9.62 0 D — — (F4) Shares disposed pursuant to a 10b5-1 plan dated August 17, 2023.
3 Common Common Shares 2024-04-17 S D 22,222 $9.91 22,222 D — — (F3) Shares disposed pursuant to a 10b5-1 plan dated August 17, 2023.
4 Common Common Shares 2024-04-18 S A 22,222 $2.31 44,444 D — — (F2) Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.
5 Derivative Common Shares 2024-04-17 M D 22,222 $2.31 449,135 D $2.31 · 2014-04-25 to 2024-04-25 22,222 Options (F5) Option exercise made pursuant to a 10b5-1 plan dated August 17, 2023.
6 Derivative Common Shares 2024-04-18 M D 22,222 $2.31 426,913 D $2.31 · 2014-04-25 to 2024-04-25 22,222 Options (F6) Option exercise made pursuant to a 10b5-1 plan dated August 17, 2023.